Drug intelligence / Profile preview

740YP

Development stage
Unknown
Lead developer
National Foundation for Fertility Research
Modality
Peptides
Administration
Ex Vivo
01

Overview

740YP is a cell-permeable phosphopeptide that acts as a potent and specific activator of phosphoinositide 3-kinase (PI3K). It consists of a sequence derived from the platelet-derived growth factor receptor (PDGFR) phosphorylated at Tyr-740, coupled to a cell-penetrating peptide sequence (Antennapedia). 740YP works by binding to the SH2 domains of the p85 regulatory subunit of PI3K, thereby mimicking the natural activation process and stimulating the PI3K/Akt/mTOR signaling pathway. In clinical research led by the National Foundation for Fertility Research, 740YP is utilized in an 'In Vitro Activation' (IVA) protocol for women with primary ovarian insufficiency (POI) and infertility. In this procedure, ovarian tissue is treated ex vivo with 740YP and the PTEN inhibitor bpV(hopic) to awaken dormant primordial follicles before being autografted back into the patient to restore reproductive function.

Other names
740 Y-PPI3K Activator 740YPPI-3K Activator 740YPPI 3K Activator 740YPPDGFR-phosphorylated peptide
02

Targets

PIK3R1 (Phosphatidylinositol 4-phosphate 3-kinase regulatory subunit alpha)

Beyond the preview

Go deeper on 740YP.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 740YP.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call